Clinicopathological and Molecular Characteristics of Early-Onset Stage III Colon Adenocarcinoma: An Analysis of the ACCENT Database
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinicopathological and Molecular Characteristics of Early-Onset Stage III Colon Adenocarcinoma: An Analysis of the ACCENT Database
Authors
Keywords
-
Journal
JNCI-Journal of the National Cancer Institute
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2021-06-22
DOI
10.1093/jnci/djab123
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of the Change of Outcomes over a Ten-Year Period in Patients with Stage III Colon Cancer: Pooled Analysis of 6501 Patients Treated with Fluorouracil, Leucovorin, and Oxaliplatin in the ACCENT Database
- (2020) M.E. Salem et al. ANNALS OF ONCOLOGY
- Colorectal cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Early-onset colorectal cancer: initial clues and current views
- (2020) Lorne J. Hofseth et al. Nature Reviews Gastroenterology & Hepatology
- Potential impact of family history–based screening guidelines on the detection of early‐onset colorectal cancer
- (2020) Samir Gupta et al. CANCER
- Pembrolizumab versus chemotherapy for microsatellite instability-high/mismatch repair deficient metastatic colorectal cancer: The phase 3 KEYNOTE-177 Study.
- (2020) Thierry Andre et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Clinical and molecular characterization of early-onset colorectal cancer
- (2019) Alexandra N. Willauer et al. CANCER
- POLEM: Avelumab plus fluoropyrimidine-based chemotherapy as adjuvant treatment for stage III dMMR or POLE exonuclease domain mutant colon cancer—A phase III randomized study.
- (2019) David Lau et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized trial of standard chemotherapy alone or combined with atezolizumab as adjuvant therapy for patients with stage III colon cancer and deficient mismatch repair (ATOMIC, Alliance A021502).
- (2019) Frank A. Sinicrope et al. JOURNAL OF CLINICAL ONCOLOGY
- Changes in colorectal cancer incidence in seven high-income countries: a population-based study
- (2019) Marzieh Araghi et al. Lancet Gastroenterology & Hepatology
- Epidemiology and Mechanisms of the Increasing Incidence of Colon and Rectal Cancers in Young Adults
- (2019) Elena M. Stoffel et al. GASTROENTEROLOGY
- Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society
- (2018) Andrew M. D. Wolf et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The Association Between Mutations in BRAF and Colorectal Cancer–Specific Survival Depends on Microsatellite Status and Tumor Stage
- (2018) Hendrik Bläker et al. Clinical Gastroenterology and Hepatology
- Evaluating the Combination of Microsatellite Instability and Mutation in BRAF as Prognostic Factors for Patients With Colorectal Cancer
- (2018) Frank A. Sinicrope Clinical Gastroenterology and Hepatology
- Left-Sided Dominance of Early-Onset Colorectal Cancers
- (2018) Lior Segev et al. DISEASES OF THE COLON & RECTUM
- Nivolumab in the treatment of microsatellite instability high metastatic colorectal cancer
- (2018) Amir Mehrvarz Sarshekeh et al. Future Oncology
- Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer
- (2018) Michael J. Overman et al. JOURNAL OF CLINICAL ONCOLOGY
- Lipidomic profiling reveals soluble epoxide hydrolase as a therapeutic target of obesity-induced colonic inflammation
- (2018) Weicang Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Colorectal Cancer Incidence Patterns in the United States, 1974–2013
- (2017) Rebecca L. Siegel et al. JNCI-Journal of the National Cancer Institute
- Colorectal Cancer Incidence Patterns in the United States, 1974–2013
- (2017) Rebecca L. Siegel et al. JNCI-Journal of the National Cancer Institute
- Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer
- (2017) Rachel Pearlman et al. JAMA Oncology
- Colorectal cancer outcomes and treatment patterns in patients too young for average-risk screening
- (2016) Zaid M. Abdelsattar et al. CANCER
- Understanding the contribution of family history to colorectal cancer risk and its clinical implications: A state-of-the-science review
- (2016) Jan T. Lowery et al. CANCER
- Efficacy of Adjuvant Chemotherapy in Colon Cancer With Microsatellite Instability: A Large Multicenter AGEO Study
- (2016) David Tougeron et al. JNCI-Journal of the National Cancer Institute
- Different risk factors for advanced colorectal neoplasm in young adults
- (2016) Ji Yeon Kim et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Efficacy of Adjuvant Chemotherapy in Colon Cancer With Microsatellite Instability: A Large Multicenter AGEO Study
- (2016) David Tougeron et al. JNCI-Journal of the National Cancer Institute
- Prognostic Effect ofBRAFandKRASMutations in Patients With Stage III Colon Cancer Treated With Leucovorin, Fluorouracil, and Oxaliplatin With or Without Cetuximab
- (2016) Julien Taieb et al. JAMA Oncology
- Molecular Markers Identify Subtypes of Stage III Colon Cancer Associated With Patient Outcomes
- (2015) Frank A. Sinicrope et al. GASTROENTEROLOGY
- Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According toBRAFMutation and Mismatch Repair Status of the MOSAIC Study
- (2015) Thierry André et al. JOURNAL OF CLINICAL ONCOLOGY
- The Worse Prognosis of Right-Sided Compared with Left-Sided Colon Cancers: a Systematic Review and Meta-analysis
- (2015) Masashi Yahagi et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Primary Tumor Location as a Prognostic Factor in Metastatic Colorectal Cancer
- (2015) Fotios Loupakis et al. JNCI-Journal of the National Cancer Institute
- Increasing Disparities in the Age-Related Incidences of Colon and Rectal Cancers in the United States, 1975-2010
- (2015) Christina E. Bailey et al. JAMA Surgery
- Primary Tumor Location as a Prognostic Factor in Metastatic Colorectal Cancer
- (2015) Fotios Loupakis et al. JNCI-Journal of the National Cancer Institute
- Comparison of Outcomes After Fluorouracil-Based Adjuvant Therapy for Stages II and III Colon Cancer Between 1978 to 1995 and 1996 to 2007: Evidence of Stage Migration From the ACCENT Database
- (2013) Qian Shi et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Impact of Deficient DNA Mismatch Repair in Patients With Stage III Colon Cancer From a Randomized Trial of FOLFOX-Based Adjuvant Chemotherapy
- (2013) Frank A. Sinicrope et al. JOURNAL OF CLINICAL ONCOLOGY
- Correlation of tumour BRAF mutations andMLH1methylation with germline mismatch repair (MMR) gene mutation status: a literature review assessing utility of tumour features for MMR variant classification
- (2012) Michael T Parsons et al. JOURNAL OF MEDICAL GENETICS
- Young-Onset Colorectal Cancer: Is It Time to Pay Attention?
- (2011) Y. Nancy You ARCHIVES OF INTERNAL MEDICINE
- Cancer statistics, 2011
- (2011) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer
- (2010) Daniel J. Sargent et al. JOURNAL OF CLINICAL ONCOLOGY
- Young-Onset Colorectal Cancer in Patients With No Known Genetic Predisposition
- (2008) Eric J. Dozois et al. MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now